Northwestern Mutual Wealth Management
ITCI

Northwestern Mutual Wealth Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51
Closed -$4.26K – 4003
2024
Q4 		$4.26K Sell
51
-6
-11% -$493 ﹤0.01% 2991
2024
Q3 		$4.17K Buy
57
+12
+27% +$902 ﹤0.01% 2949
2024
Q2 		$3.08K Buy
45
+37
+463% +$2.57K ﹤0.01% 3000
2024
Q1 		$554 Sell
8
-7
-47% -$481 ﹤0.01% 3275
2023
Q4 		$1.07K Buy
+15
New +$863 ﹤0.01% 3164
2023
Q2 		– Sell
-3
Closed -$162 – 3661
2023
Q1 		$162 Sell
3
-32
-91% -$1.55K ﹤0.01% 3206
2022
Q4 		$1.85K Buy
+35
New +$1.75K ﹤0.01% 2966
2022
Q1 		– Sell
-10
Closed -$1K – 3459
2021
Q4 		$1K Buy
+10
New +$420 ﹤0.01% 3078
2019
Q4 		– Sell
-2,000
Closed -$15K – 2654
2019
Q3 		$15K Buy
+2,000
New +$19.2K ﹤0.01% 1814

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northwestern Mutual Wealth Management's ITCI Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 51 shares — an estimated $4.26K sold.

Northwestern Mutual Wealth Management first reported a position in ITCI in Q3 2019 and held it in 9 quarters. The position peaked at $15K in Q3 2019. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Northwestern Mutual Wealth Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 51 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $4.26K.
  • Northwestern Mutual Wealth Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2019 and held it in 9 quarters.
  • Northwestern Mutual Wealth Management's Intra-Cellular Therapies Inc. position peaked at $15K in Q3 2019.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.